Active	Status	Sponsor type	Region	Phase	Filter
2 Active 7 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Avelar, Rui
EVOLUS-CLIN201, NCT05320393: Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines	Completed	2	154	US	PrabotulinumtoxinA-Xvfs, Jeuveau, OnabotulinumtoxinA, Botox Cosmetic	Evolus, Inc., ethica Clinical Research Inc.	Glabellar Frown Lines	05/23	05/23
NCT05481931: Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines	Recruiting	N/A	750	Europe	prabotulinumtoxinA, Jeuveau, Nuceiva	Evolus, Inc., Avania	Glabellar Frown Lines	12/25	01/26